ADAMIS ANTHONY P
SEC insider (Form 3/4/5 filer). CIK 0001277479. Director at Kalaris Therapeutics, Inc. (KLRS). 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 3, 2026. Located in BERKELEY HEIGHTS, NJ.
Companies ADAMIS ANTHONY P has filed insider reports for
- Kalaris Therapeutics, Inc. (KLRS): Director
ADAMIS ANTHONY P
CIK: 0001277479
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Kalaris Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 3, 2026KLRS
Kalaris Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
9K shares- - Apr 10, 2025KLRS
Kalaris Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
18K shares- - Mar 18, 2025KLRS
Kalaris Therapeutics, Inc.
AwardDirectStock Option (right to buy)
19.5K shares- - Mar 18, 2025KLRS
Kalaris Therapeutics, Inc.
AwardDirectStock Option (right to buy)
13K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 3, 2026 | KLRS Kalaris Therapeutics, Inc. | Award Stock Option (Right to Buy) | 9,000 | - | - | Direct |
| Apr 10, 2025 | KLRS Kalaris Therapeutics, Inc. | Award Stock Option (Right to Buy) | 18,000 | - | - | Direct |
| Mar 18, 2025 | KLRS Kalaris Therapeutics, Inc. | Award Stock Option (right to buy) | 19,484 | - | - | Direct |
| Mar 18, 2025 | KLRS Kalaris Therapeutics, Inc. | Award Stock Option (right to buy) | 12,989 | - | - | Direct |
1-4 of 4 transactions